Approval · Notice of Compliance 11052 · 2010
PROLASTIN-C: Notice of Compliance 11052
Issued February 15, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11052
- Date
- February 15, 2010
- Company
- Talecris Biotherapeutics, Inc.Clayton, North Carolina, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Modified manufacturing process and name change
- Therapeutic class
- Alpha-1 antitrypsin replenisher
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROLASTIN-C | Not yet assigned | — |
Medicinal ingredients
- ALPHA1-PROTEINASE INHIBITOR (HUMAN) 1,000 MG per VIAL